Loxapine Succinate as a Neuroleptic Agent: Evaluation in Two Populations of Elderly Psychiatric Patients
- 1 June 1978
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 26 (6) , 263-267
- https://doi.org/10.1111/j.1532-5415.1978.tb02400.x
Abstract
Loxapine succinate, a newly developed neuroleptic drug, was administered to two groups of geropsychiatric patients: (a) 12 with psychosis and organic brain syndrome, and (b) 14 with chronic schizophrenia. After a two-week baseline period, loxapine was given for 12 weeks. The moderate therapeutic effect of loxapine in the "responders" was similar to that of other neuroleptic drugs. The therapeutic dosage range was found to be from 10 to 80 mg daily--about half that used for younger patients. The chief side effects were drowsiness, mild extrapyramidal symptoms, and a slight increase in blood pressure.Keywords
This publication has 5 references indexed in Scilit:
- The Use of Psychoactive Drugs in Elderly Patients with Psychiatric Disorders: Survey Conducted in Twelve Veterans Administration HospitalsJournal of the American Geriatrics Society, 1975
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophreniaJournal of Clinical Psychology, 1965
- The Brief Psychiatric Rating ScalePsychological Reports, 1962